首页> 美国卫生研究院文献>Acta Crystallographica. Section D Structural Biology >High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design
【2h】

High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design

机译:酪氨酸磷酸酶epsilon D1和D2域的高分辨率晶体结构用于基于结构的药物设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Here, new crystal structures are presented of the isolated membrane-proximal D1 and distal D2 domains of protein tyrosine phosphatase epsilon (PTP∊), a protein tyrosine phosphatase that has been shown to play a positive role in the survival of human breast cancer cells. A triple mutant of the PTP∊ D2 domain (A455N/V457Y/E597D) was also constructed to reconstitute the residues of the PTP∊ D1 catalytic domain that are important for phosphatase activity, resulting in only a slight increase in the phosphatase activity compared with the native D2 protein. The structures reported here are of sufficient resolution for structure-based drug design, and a microarray-based assay for high-throughput screening to identify small-molecule inhibitors of the PTP∊ D1 domain is also described.
机译:在这里,提出了蛋白质酪氨酸磷酸酶ε(PTP∊)的分离的膜近端D1和远端D2结构域的新晶体结构,蛋白质酪氨酸磷酸酶已被证明在人类乳腺癌细胞的存活中起着积极的作用。还构建了PTP1 D2结构域的三重突变体(A455N / V457Y / E597D),以重构PTP1 D1催化结构域的残基,这些残基对于磷酸酶活性很重要,与磷酸酶相比,磷酸酶活性仅略有增加。天然D2蛋白。本文报道的结构具有足够的分辨率,可用于基于结构的药物设计,并且还描述了基于微阵列的分析方法,可用于高通量筛选,以鉴定PTP∊ D1结构域的小分子抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号